Glucosylated deferiprone and its brain uptake: Implications for developing glucosylated hydroxypyridinone analogues intended to cross the blood?brain barrier

Journal of Medicinal Chemistry

Volumn 53, Issue 15, 2010, Pages 5886-5889

  Roy, Sourav ^a   Preston, Jane E ^a   Hider, Robert C ^a   Ma, Yong Min ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 4 PYRIDONE DERIVATIVE; DEFERIPRONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG PENETRATION; DRUG UPTAKE; GLYCOSYLATION; GUINEA PIG; ISOTOPE LABELING; MALE; NONHUMAN; PKA;

ANIMALS; BLOOD-BRAIN BARRIER; GLYCOSYLATION; GUINEA PIGS; IRON CHELATING AGENTS; MALE; PYRIDONES; RATS; TISSUE DISTRIBUTION;

EID: 77955408372     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm100380k     Document Type: Article

References (14)

1. Boddaert, N.; Le Quan Sang, K. H.; Rotig, A.; Leroy-Willig, A.; Gallet, S.; Brunelle, F.; Sidi, D.; Thalabard, J. C.; Munnich, A.; Cabantchik, Z. I. Selective iron chelation in Friedreich ataxia: biologic and clinical implications Blood 2007, 110 (1) 401-408
2. Kelley, B. J.; Knopman, D. S. Alternative medicine and Alzheimer disease Neurologist 2008, 14 (5) 299-306
3. Molina-Holgado, F.; Gaeta, A.; Francis, P. T.; Williams, R. J.; Hider, R. C. Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells J. Neurochem. 2008, 2466-2476
4. Schugar, H.; Green, D. E.; Bowen, M. L.; Scott, L. E.; Storr, T.; Bohmerle, K.; Thomas, F.; Allen, D. D.; Lockman, P. R.; Merkel, M.; Thompson, K. H.; Orvig, C. Combating Alzheimer's disease with multifunctional molecules designed for metal passivation Angew. Chem., Int. Ed. Engl. 2007, 46 (10) 1716-1718
5. Kroger, L.; Henkensmeier, D.; Schäfer, A.; Thiem, J. Novel O -glycosyl amino acid mimetics as building blocks for O -glycopeptides act as inhibitors of galactosidases Bioorg. Med. Chem. Lett. 2004, 14 (1) 73-75
6. Preston, J. E.; al-Sarraf, H.; Segal, M. B. Permeability of the developing blood?brain barrier to 14C-mannitol using the rat in situ brain perfusion technique Brain Res. Dev. Brain Res. 1995, 87 (1) 69-76
7. Gibbs, J. E.; Gaffen, Z.; Thomas, S. A. Nevirapine uptake into the central nervous system of the Guinea pig: an in situ brain perfusion study J Pharmacol. Exp. Ther. 2006, 317 (2) 746-751
8. Liu, D. Y.; Liu, Z. D.; Lu, S. L.; Hider, R. C. Gradient ion-pair high-performance liquid chromatographic method for analysis of 3-hydroxypyridin-4-one iron chelators J Chromatogr., B: Biomed. Sci Appl. 1999, 730 (1) 135-139
9. Liu, X.; Chen, C.; Smith, B. J. Progress in brain penetration evaluation in drug discovery and development J Pharmacol. Exp. Ther. 2008, 325 (2) 349-356
10. Illum, L.; Davis, S. S.; Pawula, M.; Fisher, A. N.; Barrett, D. A.; Farraj, N. F.; Shaw, P. N. Nasal administration of morphine-6-glucuronide in sheep-a pharmacokinetic study Biopharm. Drug Dispos. 1996, 17 (8) 717-724
11. Hammarlund-Udenaes, M.; Friden, M.; Syvanen, S.; Gupta, A. On the rate and extent of drug delivery to the brain Pharm. Res. 2008, 25 (8) 1737-1750
12. Summerfield, S. G.; Lucas, A. J.; Porter, R. A.; Jeffrey, P.; Gunn, R. N.; Read, K. R.; Stevens, A. J.; Metcalf, A. C.; Osuna, M. C.; Kilford, P. J.; Passchier, J.; Ruffo, A. D. Toward an improved prediction of human in vivo brain penetration Xenobiotica 2008, 38 (12) 1518-1535
13. Storr, T.; Merkel, M.; Song-Zhao, G. X.; Scott, L. E.; Green, D. E.; Bowen, M. L.; Thompson, K. H.; Patrick, B. O.; Schugar, H. J.; Orvig, C. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy J. Am. Chem. Soc. 2007, 129 (23) 7453-7463
14. Kroger, L.; Thiem, J. Convenient multigram scale glycosylations of scented alcohols employing phase-transfer reactions J. Carbohydr. Chem. 2003, 22 (1) 9-23